Φορτώνει......
Potential biomarkers to follow the progression and treatment response of Huntington’s disease
Huntington’s disease (HD) is a rare genetic disease caused by expanded polyglutamine repeats in the huntingtin protein resulting in selective neuronal loss. Although genetic testing readily identifies those who will be affected, current pharmacological treatments do not prevent or slow down disease...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Exp Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
The Rockefeller University Press
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5110026/ https://ncbi.nlm.nih.gov/pubmed/27821553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20160776 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|